The decision by NHS watchdog NICE not to treat depression with ketamine due to high costs and a lack of evidence “seems very sensible,” says Honorary Professor David Curtis (UCL Genetics, Evolution & Environment).
Read: Mail Online, More: Yahoo! News
Close
